Indian partner plans to manufacture, test and commercialise the injectable vaccine in the country where the Covid-19 vaccine market is expected to grow to over $2.3 billion by 2027
The test kit can produce results within 30 minutes for both symptomatic and asymptomatic patients.
According to senior doctors in Hyderabad, at some point in the near future, as the protection provided by Covid vaccines wane, there will be demand for booster shots
Public health officials warn public not to get complacent and allow virus to regain foothold
The study, led by researchers from the Indian Institute of Technology, Guwahati, and University of Massachusetts, showed that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice.
Vaccination rate must go up 3-fold to cover 80% of adult population by Sept, given the rapid mutation of the virus
The origins of the COVID-19 remain a widely debated topic, with some scientists and politicians maintaining that the possibility of a lab leak of the deadly virus exists.
It was developed indigenously by scientists, followed by extensive validation on over 1000 patient samples at various COVID hospitals in Delhi.
A team of scientists from Hokkaido University in Japan used a novel antigen-based kit, Lumipulse SARS-CoV-2 Ag kit (Lumipulse), developed by a Japanese company Fujirebio
The B1617 variant was, till now, deemed a 'variant of interest' by the WHO.
Covid-19 drug candidate has been developed by VINS Bioproducts in collaboration with Centre for Cellular and Molecular Biology and University of Hyderabad
Double mutant strains found in 4-5% of samples in Telangana
Large-scale supercomputer simulations at the atomic level showed that the dominant "G form" variant of the Covid-19 causing virus is more infectious partly.
The trend could be an indication that the community and healthcare infrastructure in Telangana might be under stress for a prolonged period due to new Covid infections
- Advertisement -